{ 
	"_id" : ObjectId("53640f141d1d57023ae79097"), 
	"sourceType" : "RSSFeed",
	"link" : "http://www.reuters.com/article/2014/05/02/us-astrazeneca-pfizer-idUSBREA3R0H520140502",
	"text" : "AstraZeneca rejects Pfizer's raised bid of $106 billion\n LONDON (Reuters) - U.S. drugmaker Pfizer Inc increased its offer for AstraZeneca Plc to 63 billion pounds ($106 billion) on Friday, but the British company promptly rejected the proposal, which would create the world's biggest pharmaceuticals company.", 
	"vectors" : { 
		"LSA_RSSFeed" : [-2.3976837736506664, -1.9210877060050602, 0.061378968110965985 , -0.7542352064391101, -0.548455201126516, -0.5686231605046921, -0.3612243397402895, 0.28496188476707407, -0.4696916380893701, 0.19403996177526886, -0.08751882828384312, -0.2694885106561084, -0.34228071146762906, -0.1729856177113159, -0.11331418028886636, 0.10331047932112887, 0.16466475435830158, -0.24991690667109162, -0.19933651607584285, -0.05195826265951706, 0.5175310678495657, -0.7456512168922975, -0.017126553554314035, -0.10026527918487693, -0.15992487746874415, -0.37448836616374703, 0.28815364731016624, -0.3385546236737824, -0.46236204808320724, -0.21503313651856, 0.32131779607135136, -0.11446031569337956, 0.1157326842488579, -0.06013088357653178, -0.027202039586637704, -0.10099792034640784, -0.18463547023097324, -0.11622237190060242, -0.36561462801530314, -0.4680915280836317, -0.41779311783418627, -0.2638805599585434, -0.045208764325683194, -0.46652174440217115, -0.913093492399355, 0.4979782254357446, -0.04592621385801966, -0.06363839468657166, -0.7236828440164556, 0.29603155898757016, 0.04853151896654664, -0.20178515517963802, -0.35815985007075707, 0.1144270820171216, 0.6351355989811955, -0.10375778189876077, -0.674848883376427, -0.5883745516961277, 0.2916549399023337, -0.05954677601974326, -0.23079347875005493, -0.8254150211840844, 0.261723073099695, 0.6573936214870132, 1.3525414702134566, -0.25346326681367193, -0.4176262985626258, 0.09692386847595683, 0.1429929536578174, 0.47286437111193347, 0.06670633764611446, -0.8303336200702015, -0.13939126494815618, 0.2208336704758063, 0.0716907462988756, 0.6567657768147829, 0.13821118970678192, -0.23845554521766701, 0.2704395191223968, 0.44632667587945046, 1.0919068460455088, 0.41932422853848095, -0.3496177591286738, -1.0913178846816736, -0.007431910123057283, 0.34797544234440386, -0.056329048718190486, -0.7001555888766713, -0.051707736336289285, -1.0006622588433953, 0.1858985857920016, -0.8187577678599006, 0.22318126227434418, -0.5127108006222668, -0.193391123284414, -0.3047481224012521, 0.2849157869772308, 0.18372220453300395, 0.3430565264485547, 0.06586729623332804 ], 
		"NamedEntities" : [ [ "GPE", "AstraZeneca" ], [ "PERSON", "Pfizer" ], [ "GPE", "LONDON" ], [ "ORGANIZATION", "Reuters" ], [ "GPE", "U.S." ], [ "PERSON", "Pfizer Inc" ], [ "ORGANIZATION", "AstraZeneca Plc" ], [ "GPE", "British" ] ] }, 
	"preprocessed" : [[3334, 1 ], [ 8033, 1 ], [ 14407, 1 ], [ 25237, 1 ], [ 25887, 1 ], [ 29952, 1 ], [ 30181, 1 ], [ 33688, 1 ], [ 38796, 1 ], [ 47800, 1 ], [ 52306, 1 ], [ 53603, 1 ], [ 73323, 1 ], [ 73755, 1 ], [ 74777, 1 ], [ 75343, 1 ], [ 77372, 1 ], [ 78412, 1 ], [ 78490, 1 ], [ 84746, 1 ], [ 86485, 1 ], [ 98945, 1 ], [ 102502, 1 ], [ 110765, 1 ], [ 115043, 1 ], [ 125752, 1 ], [ 140321, 1 ], [ 144503, 1 ], [ 158154, 1 ], [ 168513, 1 ], [ 180801, 1 ], [ 184038, 1 ], [ 188751, 1 ], [ 207686, 1 ], [ 208964, 1 ] ], 
	"id" : 839 
}
